Right
On Brands Acquires 49% Interest in Neuro Science Research
Centers
Rowlett, TX -- April 12, 2023 --
InvestorsHub NewsWire -- Right on Brands, Inc. (OTC:
RTON), a leader and innovator of HEMP
DERIVED, and WELLNESS products announced today that its Board of
Directors has approved an investment in Neuro Science Research
Centers Inc.
Neuro Science Research Centers Inc.
was formed to be one of the first licensed Psilocybin extraction
facilities in Oregon. Psilocybin is being used to treat mental
disorders and is shown to be of great benefit. The Johns Hopkins
Center for Psychedelic and Consciousness Research is leading the
way in exploring innovative treatments using psilocybin. The
molecular structure of psilocybin, a naturally occurring
psychedelic compound found in 'magic mushrooms,' allows it to
penetrate the central nervous system and the scientific and medical
experts are just beginning to understand its effects on the brain
and mind and its potential as therapeutics for mental illnesses.
Many other researchers and companies are looking to use these new
products that will come from Psilocybin.
Jerry Grisaffi, President, and CEO of
Right on Brands, stated, "We are excited to be entering into this
relationship and partnership with Neuro Science Research Centers.
Psilocybin research is still in its infancy, but with the level of
production already accomplished and continued acceptance within the
medical community using psilocybin, we believe this is an
opportunity for us to be on the ground level, yet with our
locations and distribution network we will be able to attain early
success within a reasonable timeframe." Russel Young has been named
President of the new entity and majority shareholder Mike Brown has
been name Secretary and Director. "This is a great opportunity, and
I too am excited about our relationship with Right on Brands Inc."
states Russel.
About Us
Right on Brands, Inc., is a consumer
goods company specializing in the brand development and
distribution of hemp-based foods, beverages, smokables, oils and
topical products. Right on Brands, Inc. is a developer of a broad
line of hemp-based smokables, beverages, tinctures, and topical
products including products infused with CBD, Delta-8, Delta-10,
THCV, CBDV, and Delta-9 (below the federal limit) and the all new
HHC vapes, gummies and tinctures. We will also be launching a
Kratom gummy. About ENDO Brands: ENDO Brands™, Humbly Hemp®, and
ENDO Dispensary & Wellness™ Endo Franchise Group Inc, all share
the same goal of providing our customers with the best products in
the health and wellness space. As the field of health and wellness
Endo's approach is to give their customer a holistic approach to
their wellness.
To learn more, please visit:
https://rightonbrands.com
/ www.endobrands.com
/
www.ENDOdispensaryrowlett.com
Corporate Sales Contact:
Mike Brown
(214) 299-9528 /
mike@rightonbrands.com
-
ENDO
Brands Corporate Store: ENDO Brands at
Lakeview Plaza 6501 Dalrock Road, Suite 100 Rowlett, Texas 75089
214-299-9528
-
AUSTIN
LOCATION 12412 Limerick Avenue
Austin, Texas 78758
www.endoofaustin.com 512-621-0649
-
LAREDO
LOCATION ENDO Laredo 2413
Jacaman Rd Laredo, Texas
www.endolaredo.com 956-568-2300
-
HOUSTON
LOCATION 3301 Louetta Rd Ste
109 Spring, Texas 77388 Website coming soon.
832-583-5383
-
MIAMI
FLORIDA LOCATION 10850 SW
104th
St Miami, Florida
33156
endo-miami.com 786-703-1276
-
PLANO
LOCATION 601 W. Parker Road
Plano, Texas 75023 469-366-9694
-
DALLAS
LOCATION 9585 Scyene Road
Dallas, Texas website coming soon.
Forward-Looking Statements
This press release contains
information that constitutes forward-looking statements made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. All such forward-looking statements
involve risk and uncertainties that could cause actual results to
differ materially from any future results described by the
forward-looking statements. Risk factors that could contribute to
such differences include those matters more fully disclosed in the
Company's reports filed with the SEC. The forward-looking
information provided herein represents the Company's estimates as
of the date of this press release, and subsequent events and
developments may cause the Company's estimates to change. The
Company specifically disclaims any obligation to update the
forward-looking information in the future. Therefore, this
forward-looking information should not be relied upon as
representing the Company's estimates of its future financial
performance as of any date subsequent to the date of this press
release.
Investor Relations Contact
Andrew Barwicki
516-662-9461
/
andrew@barwicki.com